Also, selective inhibition of neuronal TNFR2 enhanced the Aβ‐ and Tau‐related pathologic features of AD and diminished the activation of microglia, which is needed for clearance of Aβ (Montgomery et al, 2013). This evidence concerns the gene MAPT and Alzheimer disease.